Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03038568 · ClinicalTrials.gov registry record
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
A clinical trial of Colorectal Cancer Metastatic, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 169
- Enrollment target
- 2
- Study locations
NCT03038568 is a study of Colorectal Cancer Metastatic that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 169 participants, below the 196-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03038568, a study of Colorectal Cancer Metastatic, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 169 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variable scan parameters and variable contrast timing. Participants will be consented to undergo an additional CT of their abdomen.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT scan
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- MD Anderson Cancer Center, Texas (Data collection only) - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2026-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03038568
The ClinicalTrials.gov registry entry for NCT03038568 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 196-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (14% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer Metastatic appearing as the primary indexed condition, and to 1 intervention - of which CT scan is the first listed.
NCT03038568 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03038568 about?
NCT03038568 is a clinical study titled "Assessing How Normal Variations in CT Scanning Affects Its Interpretation". The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variabl...
What is the current status of trial NCT03038568?
This trial is currently active not recruiting. The enrollment target is 169 participants. The study started on 2017-01-27. Estimated completion is 2026-01-27.
What conditions does trial NCT03038568 study?
This clinical trial studies the following conditions: Colorectal Cancer Metastatic.
What interventions are being tested in trial NCT03038568?
The interventions under investigation include: CT scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03038568?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03038568 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Metastatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RECRUITING · Phase 2
-
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
RECRUITING
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
RECRUITING · Early Phase 1
-
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
RECRUITING
-
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
RECRUITING · Early Phase 1
-
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.